• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Agilent Technologies

Agilent Technologies

Agilent Technologies Inc A 3 Star

Last Price$42.49Day Change (%)-0.30%
Open Price$42.71Day Change ($)-0.13
Day Range42.42–42.8152-Week Range35.61–43.59

As of Fri 4/24/2015 5:58:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. William P. Sullivan Joins Edison International and Southern California Edison Boards of Directors

    William P. Sullivan Joins Edison International and Southern California Edison Boards of Directors

  2. S&P 500 back for another crack at trendline resistance

    S&P 500 back for another crack at trendline resistance

  3. Merck Announces Submission of Supplemental Biologics License Application (sBLA) to U.S. FDA for KEYTRUDA® (pembrolizumab) in Advanced Non-Small Cell Lung Cancer

    Merck Announces Submission of Supplemental Biologics License Application (sBLA) to U.S. FDA for KEYTRUDA® (pembrolizumab) in Advanced Non-Small Cell Lung Cancer

  4. Research and Markets: ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015

    Research and Markets: ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015

  5. Research and Markets: Discrete Diodes - Global Strategic Business Report 2015

    Research and Markets: Discrete Diodes - Global Strategic Business Report 2015

  6. What's the Best Way to Play a Large-Growth Rally?

    You'll be surprised at which funds are poised for a large-growth rebound.

  7. Middle East/Africa: Regional Economic Review – 3Q 2013

    Agilent A reported full-year results indicating respectable revenue growth and continued improvements to profitability. We've updated our model to reflect fiscal 2006 results and are maintaining our fair value estimate. Revenues in the bio-analytical division grew 9% over last year, matching our ...

  8. What the NHL Playoffs Can Teach Investors

    Agilent's A third-quarter gross margin was well ahead of our expectations for the quarter, and the company produced another respectable performance in year-over-year sales (15%) and order (11%) growth. The gross margin finished at 55%, much higher than our assumption for the quarter and 5 ...

  9. Selected American Shares Annual Review 2014

    This report includes candid statements and observations regarding investment strategies, individual securities, and economic and market conditions; however, there is no guarantee that these statements, opinions or forecasts will prove to be correct. Equity markets are volatile and an investor may ...

  10. Semiconductor Industry Outlook – April 2011

    The information and opinions presented herein are not meant to be taken as investment advice. We do our best to make sure the information presented in this article is factual and correct, but Zacks cannot be held responsible for any losses incurred from investment transactions made based on ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.